Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.94 SEK | +2.17% | +3.30% | -23.58% |
May. 15 | Nanexa AB Elects Hanna Tilus as Members of the Board | CI |
May. 15 | Nanexa AB Receives Approval for NEX-22 Clinical Study | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.58% | 11.88M | |
-61.77% | 85.17M |
- Stock Market
- Equities
- NANEXA Stock
- News Nanexa AB
- Nanexa Completes Recruitment for Phase 1 Myeloma Cancer Drug Study